We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” application procedures. Justice Phelan agreed that Apotex’s allegations of non-infringement and invalidity were not justified and issued an order prohibiting the Minister of Health from issuing a notice of compliance to Apotex until after the patent expires.